Observational Study of the Additive Effects of Pranlukast on Inflammatory Markers of Clinically Stable Asthma with Inhaled Corticosteroids and Long-Acting Beta 2 Agonists

Publisher： Karger

E-ISSN： 1423-0356|76|4|398-402

ISSN： 0025-7931

Source： Respiration, Vol.76, Iss.4, 2008-08, pp. : 398-402

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting β2-agonists: addition of montelukast in an open-label pilot study

By Dupont Lieven   Potvin Emmanuel   Korn Dana   Lachman Albert   Dramaix Michèle   Gusman Julie   Peché Rudi  

Current Medical Research and Opinion, Vol. 21, Iss. 6, 2005-06 ,pp. : 863-870

Informa Healthcare

Access to resources Recommend Favorite

Evaluating Safety of Long-Acting Beta Agonists (LABAs) in Patients with Asthma

By  

Current Drug Safety, Vol. 5, Iss. 3, 2010-07 ,pp. : 245-250

Bentham Science Publishers

Access to resources Recommend Favorite

Corticosteroids plus Long-Acting Beta2-Agonists Prevent Double-Stranded RNA-Induced Upregulation of B7-H1 on Airway Epithelium

By  

International Archives of Allergy and Immunology, Vol. 160, Iss. 1, 2012-08 ,pp. : 27-36

Karger

Access to resources Recommend Favorite

Long‐acting muscarinic antagonist + long‐acting beta agonist versus long‐acting beta agonist + inhaled corticosteroid for COPD: A systematic review and meta‐analysis

By  

RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. 8, 2015-11 ,pp. : 1153-1159

John Wiley & Sons Inc

Access to resources Recommend Favorite

Indacaterol, a novel inhaled, once-daily, long-acting beta 2 -agonist for the treatment of obstructive airways diseases

By Beeh Kai  

Advances in Therapy, Vol. 26, Iss. 7, 2009-07 ,pp. : 691-699

Springer Publishing Company

Access to resources Recommend Favorite